Manufacturer
APOTEX INC. - ETOBICOKE SITE
Contents
Deferiprone (L1)
Indication
Iron overload in patient w/ thalassaemia.
Instruction
May be taken with or without food.
Drug interaction
Serum concentration may be increased by UGT1A6 inhibitors (e.g. phenylbutazone). May chelate polyvalent cations, allow at least 4-hr interval w/ antacids and mineral supplements containing Al, Fe or Zn. Risk of additive toxicity w/ drugs that may cause neutropenia or agranulocytosis.
Malaysia
